| Name | Title | Contact Details |
|---|
S.A.F.T.E. (Safety Alert for the Elderly) is a Pleasanton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Transcarent is a new consumer-directed health and care platform for employees of self-insured employers and their families. Using a combination of software, technology, Health Guides and data science, Transcarent empowers consumers with unbiased information, trusted guidance and access to high-value care.
SAFECOR HEALTH LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Mesa, AZ. To find more information about SAFECOR HEALTH LLC, please visit www.safecorhealth.com
We believe that whole food based nutrition containing collagen is essential for one`s overall health, beauty, fitness and well-being. Our ancestors utilized sustainable whole animal nutrition, which provided an abundant amount of collagen. Over the past century modern food processing has removed this natural and healthy protein from our diets. Collagen is vital for our body and is the basic building block of skin, hair, nails, bones and joints. We promote optimal health, beauty, vibrant youth, and overall wellness with our products. We are dedicated to providing 100% natural, whole food proteins that support animal well-being and sustainable eco-friendly practices. Our happy cows openly graze on lush natural grass pastures providing the highest quality of protein.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.